AV
Atea Pharmaceuticals, Inc.
AVIR · NASDAQ
$5.23 -1.32% (-$0.07)
1M +0.19%
Market Cap $418.5M
P/E Ratio -
Div. Yield -
ROE 64.25%
Bulios Fair Price
$3.76
28.1% downside
Trenutna cena
$5.23
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica AVIR trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
2/9Valuation
86 /100
Cheap P/B 2.05x
P/FCF N/A
P/FFO N/A
Growth
0 /100
Declining Book val. growth 24.52%
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A FCF margin N/A
Op. margin N/A
Gross margin N/A
Quality
0 /100
Poor Asset turnover 0.00x
ROA 71.16%
ROIC 86.35%
Debt
100 /100
Low Current ratio 8.13x
Debt/Equity 0.00x
Net debt/EBITDA N/A
Stability
51 /100
Moderate EPS volatility 13.54%
Profitable years 0
Beta 0.29x
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o AVIR
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Jean-Pierre Sommadossi
Employees
55
Headquarters
Boston
Prihajajoči dogodki
11 NOV.
Earnings
Upcoming earnings report